Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats

Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor

(2017) Tsukasa Nozu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Bowel Disorders

(2016) Brian E. Lacy et al.   GASTROENTEROLOGY

Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats

(2016) Tsukasa Nozu et al.   JOURNAL OF GASTROENTEROLOGY

Effects of Liraglutide and Vitamin E in Fructose-Induced Metabolic Syndrome in Rats

(2016) Ayman Geddawy et al.   PHARMACOLOGY

Inflammation in irritable bowel syndrome: Myth or new treatment target?

(2016) Emanuele Sinagra et al.   WORLD JOURNAL OF GASTROENTEROLOGY

GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R

(2015) Bernardo Yusta et al.   DIABETES

Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome

(2015) A. Dlugosz et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia

(2014) Hui Fan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Activation of Spinal Glucagon-Like Peptide-1 Receptors Specifically Suppresses Pain Hypersensitivity

(2014) N. Gong et al.   JOURNAL OF NEUROSCIENCE

Liraglutide ameliorates renal injury in streptozotocin-induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor-κB pathway

(2014) SAI-JUN ZHOU et al.   Molecular Medicine Reports

Tight junctions and IBS - the link between epithelial permeability, low-grade inflammation, and symptom generation?

(2014) T. Piche   NEUROGASTROENTEROLOGY AND MOTILITY

Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: Role of nitric oxide

(2013) Pedram Paragomi et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS

(2013) E. Wilcz-Villega et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Antinociceptive effect of berberine on visceral hypersensitivity in rats

(2013) Qing-Lin Tang   WORLD JOURNAL OF GASTROENTEROLOGY

Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes

(2013) Lan He et al.   Journal of Diabetes Investigation

Mucosal Permeability and Immune Activation as Potential Therapeutic Targets of Probiotics in Irritable Bowel Syndrome

(2012) Giovanni Barbara et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype

(2011) Nathalie Bertiaux-Vandaële et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Stress and visceral pain: From animal models to clinical therapies

(2011) Muriel Larauche et al.   EXPERIMENTAL NEUROLOGY

Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function

(2011) Cong Dai et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

New insights into visceral hypersensitivity—clinical implications in IBS

(2011) QiQi Zhou et al.   Nature Reviews Gastroenterology & Hepatology

Pain and analgesia: The dual effect of nitric oxide in the nociceptive system

(2011) Yara Cury et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Abdominal pain in Irritable Bowel Syndrome: A review of putative psychological, neural and neuro-immune mechanisms

(2010) Sigrid Elsenbruch   BRAIN BEHAVIOR AND IMMUNITY

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4

(2010) M. Arakawa et al.   DIABETES

Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors

(2010) A. Amato et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome

(2009) QiQi Zhou et al.   PAIN

Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study

(2008) P. M. HELLSTRÖM et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS